Mperia Therapeutics
Latest round
- Series A
Last raised
- Sep 2016
Total raised
- $0.8M
Investors
- 1
About Mperia Therapeutics
Founded in 2016 and based in Montreal, Quebec, Mperia Therapeutics Inc. is a spun-off company from Amorchem Ventures. The firm operates an immunotherapy technology that aids chronic inflammation and age-related macular degeneration.
Who invested in Mperia Therapeutics
1 investor across 1 round
See all investors in Mperia Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Sep 12, 2016
Amount
$0.8M
Investors
Questions about Mperia Therapeutics
Who invested in Mperia Therapeutics?
Mperia Therapeutics has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Mperia Therapeutics raised?
Mperia Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Mperia Therapeutics last raise money?
Mperia Therapeutics's most recent round on record is a Series A, in Sep 2016.
What does Mperia Therapeutics do?
Founded in 2016 and based in Montreal, Quebec, Mperia Therapeutics Inc.
Where is Mperia Therapeutics headquartered?
Mperia Therapeutics is headquartered in Montreal, Canada.
Which VCs invest in companies like Mperia Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Mperia Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Mperia Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.